Advertisement

---

NAUREX INC.

Naurex Announces Initiation Of Phase I Trial For Second-Generation Novel Antidepressant Agent NRX-1074

[2013-06-04] - New NMDA Receptor Modulator Is Orally Available Follow-on to Rapidly-Acting Lead Compound GLYX-13


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers